Trading Signals: TRVN Stock Price Prediction and Forecast (Thu. Jan. 30, 2014 - Fri. Feb. 17, 2017)(Trevena, Inc.)
| Market is closed on Mon. Jul. 13, 2020 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TRVN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TRVN price | TRVN will advance at least -0% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | NAN% | | | |
|
Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA. |